State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Stomach (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.5 to 3.5 and 14,088 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

New York⁷

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.3 to 4.5 and 1,109 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 3)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 3.7 to 5.1 and 34 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 20)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 4.3 with a 95% confidence interval from 4.2 to 4.4 and 1,909 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 4)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.8 to 4.1 and 616 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (3, 9)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.5 to 4.4 and 78 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 21)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.6 to 4.2 and 141 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (2, 17)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.6 to 4.1 and 183 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (3, 17)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.6 to 3.9 and 435 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (4, 15)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 209 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (4, 20)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.6 to 3.8 and 1,111 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (6, 15)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.2 to 4.2 and 47 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (2, 38)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.2 to 4.1 and 51 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (2, 36)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.5 to 3.8 and 437 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (6, 20)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.4 to 3.8 and 272 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (6, 23)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.7 and 266 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (6, 25)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.3 to 3.6 and 599 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (11, 24)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.8 to 4.1 and 23 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (2, 50)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.2 to 3.6 and 302 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (10, 29)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.2 to 3.5 and 431 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (12, 28)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.5 and 221 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (11, 34)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.4 and 431 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (14, 33)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.4 and 253 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (13, 35)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.5 and 181 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (13, 38)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 292 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (15, 37)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.1 to 3.3 and 981 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (19, 34)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.8 to 3.5 and 64 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (9, 49)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.6 to 3.7 and 28 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (4, 51)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 3.0 to 3.2 and 465 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (20, 39)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.8 to 3.4 and 83 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (13, 48)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 216 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (17, 43)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 253 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (19, 43)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.8 to 3.3 and 115 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (16, 47)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.8 to 3.3 and 107 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (16, 48)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.9 to 3.2 and 309 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (22, 45)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.3 and 68 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (15, 50)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.2 and 136 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (21, 49)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.3 and 54 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (15, 51)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.5 to 3.3 and 41 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (13, 51)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.4 to 3.4 and 26 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (10, 51)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.1 and 183 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (25, 50)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.1 and 157 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (26, 50)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.7 to 3.0 and 258 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (29, 49)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 113 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (26, 51)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 2.9 and 236 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (32, 50)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.1 and 72 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (22, 51)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 178 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (31, 51)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.3 to 3.2 and 29 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (17, 51)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 2.9 and 100 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (31, 51)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.3 to 3.0 and 56 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (27, 51)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.3 to 2.9 and 76 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (34, 51)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 2.2 with a 95% confidence interval from 1.7 to 2.7 and 17 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (35, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.4 to 2.9 and 132 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/22/2026 11:40 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.